Ligand validation:3EJE

HEM: PROTOPORPHYRIN IX CONTAINING FE

HEM is a Ligand Of Interest in 3EJE designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3EJE_HEM_B_405	78%	21%	0.125	0.969	2.13	1.36	6	1	1	0	100%	1
3EJE_HEM_F_405	75%	21%	0.129	0.963	2.13	1.38	5	2	1	0	100%	1
3EJE_HEM_D_405	73%	21%	0.135	0.962	2.14	1.33	7	2	1	0	100%	1
3EJE_HEM_H_405	72%	21%	0.134	0.959	2.14	1.35	6	1	3	0	100%	1
3EJB_HEM_D_405	84%	19%	0.111	0.973	1.94	1.66	6	5	1	0	100%	1
3EJD_HEM_B_405	81%	20%	0.12	0.973	2.12	1.42	6	3	2	0	100%	1
5YCE_HEM_A_201	100%	38%	0.036	0.997	1.14	1.34	2	6	1	0	100%	1
1GWE_HEM_A_504	100%	44%	0.041	0.998	0.98	1.21	1	6	0	0	100%	1
3X34_HEM_A_101	100%	25%	0.043	0.997	1.01	2.19	2	8	2	0	100%	0.8972
1BZ6_HEM_A_154	100%	40%	0.044	0.995	1.19	1.21	3	4	0	0	100%	1
1PA2_HEM_A_306	100%	12%	0.044	0.995	1.65	2.54	9	16	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.